发明名称 ACTIVE PULSE BLOOD CONSTITUENT MONITORING
摘要 A blood glucose monitoring system (100) is disclosed which provides for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium (310) under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector (320) which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
申请公布号 WO9639926(A1) 申请公布日期 1996.12.19
申请号 WO1996US08505 申请日期 1996.06.04
申请人 MASIMO CORPORATION 发明人 KIANI-AZARBAYJANY, ESMAIEL;DIAB, MOHAMED, KHEIR;LEPPER, JAMES, M., JR.
分类号 G01N21/35;A61B5/00;A61B5/145;A61B5/1455;(IPC1-7):A61B5/00 主分类号 G01N21/35
代理机构 代理人
主权项
地址